5540-03-4Relevant academic research and scientific papers
THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE
-
, (2008/12/07)
[PROBLEMS] To provide a neuronal cell death inhibitor and a therapeutic agent for a neurodegenerative disease, particularly Perkinson's disease. [MEANS FOR SOLVING PROBLEMS] It is known that DJ-1 protein is involved in Perkinson's disease and is capable o
PEPTIDE BOND FORMATION UNDER PHASE-TRANSFER CONDITIONS. EFFECT OF AMINO ACID STRUCTURE
Kosmynin, V. V.,Kaida, L. N.,Savelova, V. A.,Taran, N. A.
, p. 2306 - 2311 (2007/10/02)
The extraction of amino acids NH2CH(R)COOH in the two-phase system consisting of 1-butanol and an amino acid buffer solution in the presence of cetyltrimethylammonium bromide and also the kinetics of the aminolysis of N-benzyloxycarbonylglycine p-nitrophe
Composition containing a penem or carbapenem antibiotic
-
, (2008/06/13)
Administration of an N-acylated amino acid in association with a penem or carbapenem antibiotic relieves or eliminates the renal problems associated with administration of the antibiotic alone. The amino acid derivative and antibiotic may be formulated together as a composition or administered separately, either simultaneously or sequentially. The composition may be prepared by simple mixing.
Peptide amides and process for their manufacture
-
, (2008/06/13)
New peptide amides of the formula I wherein For is formyl, X is alkylamino, dehydro-Phe or Phe-alkylamido having up to 6 carbon atoms in the alkyl moiety, which moiety may be substituted by hydroxy and/or phenyl, Phe-cycloalkylamide or Phe-cyc
